Late toxicity and quality of life from GETUG-AFU 22 study: A randomized phase II trial comparing 6 months of degarelix in combination with radiotherapy to radiotherapy alone for patients with detectable PSA after radical prostatectomy

Bibliographic Details
Main Authors:	P. Sargos, S. Guerif, J. Fraisse, E. Meyer, S. Supiot, E. Lagneau, E. Deniaud-Alexandre, P. Rochin, A. Benyoucef, L. Cartier, H. Hamidou, A. Hasbini, G. Crehange, P. Pommier, G. De Laroche, S. Pelissier, E. Gross, P. Fourneret, L. Salomon, I. Latorzeff
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320335229

Internet